Abstract
In this report, the authors summarize updated results with adjuvant immunotherapy with bacillus Calmette-Guerin (BCG) for patients with recurrent malignant melanoma. This program was initiated in 1971.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 359-362 |
| Number of pages | 4 |
| Journal | Recent Results in Cancer Research |
| Volume | Vol. 68 |
| DOIs | |
| State | Published - 1979 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Immunotherapy for recurrent malignant melanoma: Efficacy of BCG in prolonging the postoperative disease free interval and survival'. Together they form a unique fingerprint.
Cite this
Gutterman, J. U., Richman, S. P., & McBride, C. M. (1979). Immunotherapy for recurrent malignant melanoma: Efficacy of BCG in prolonging the postoperative disease free interval and survival. Recent Results in Cancer Research, Vol. 68, 359-362. https://doi.org/10.1007/978-3-642-81332-0_53